New
NeedleAID by DECAP
The AI engine Fit Assessment
BetaThe company will be attending ViVE 2025 Event
Blurb
Developer of needle safety devices for healthcare, veterinary, and research workers. NeedleAID by DECAP Research and Development offers safer solutions for clinics, hospitals, and at-home use, with a design that reduces the risk of needlestick injuries.
HQ Location
Canada
Founded
2018
Employees
1 - 10
Total funding raised
Not available
Last Funding Event
Not available
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Developer of needle safety devices for healthcare, veterinary, and research workers. NeedleAID by DECAP Research and Development offers safer solutions for clinics, hospitals, and at-home use, with a design that reduces the risk of needlestick injuries. The company meets regulatory standards for needle safety in Canada, the USA, and the EU. NeedleAID has been tested in over 100 laboratory, research, and clinical environments over the past 3 years.